Sophie Grande

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy

Pia Gamradt, Léo Laoubi, Audrey Nosbaum et al. · Journal of Allergy and Clinical Immunology · 2019 · 93 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial

C. Goujon, M. Viguier, D. Staumont‐Sallé et al. · The Journal of Allergy and Clinical Immunology In Practice · 2017 · 92 citations

Medicine, Dermatology, Immunology +14

GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis

M. Larsabal, S. Ly, É. Sbidian et al. · British Journal of Dermatology · 2018 · 78 citations

Medicine, Dermatology, Andrology +9

Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review

Jean Kanitakis, Carole Allombert, Bénédicte Doebelin et al. · Journal of Cutaneous Pathology · 2005 · 53 citations

Medicine, Dermatology, Pathology +8